Risk-Based Approaches that Impress FDA Investigators
March 25 - March 27
Philadelphia, United States
Data Integrity remains the life science industry’s greatest challenge as Warning Letters continue to rise year-over-year. These serious findings include; having interrupted, missing, deleted and lost data; inadequate records for risk analysis; failure to exercise appropriate controls; failure to validate computer software; failure to establish validation procedures; manipulation and deletion of audit trails; and many more. The time has never been more critical to evaluate and ensure your organization has top-notch compliant procedures. KENX is pleased to announce that our Data Integrity Inspection Readiness Summit is headed to Philadelphia to showcase the protocols, methodology and actions necessary to avoid regulatory action.
Personnel in the Following Environments Should Attend:
This event is also appropriate to business development and sales managers that offer innovative solutions for data integrity, validation, quality and data collection environments.
This Conference is Co-Located with VALIDATION UNIVERSITY with In-Depth Coverage On: